[1]
Vyas, M. et al. 2017. SOLUBILITY ENHANCEMENT OF EFAVIRENZ (BCS CLASS II DRUG) BY CYCLODEXTRIN INCLUSION COMPLEX TECHNIQUE. Journal of Drug Delivery and Therapeutics. 7, 7 (Dec. 2017), 41–43. DOI:https://doi.org/10.22270/jddt.v7i7.1581.